Feasibility of a Compassionate Same-Day Evaluation and Delivery of Single Fraction Radiotherapy for Palliation of Symptomatic Bony Metastasis in Hospice Patients
- Symptomatic osseous bone lesion(s) from any malignancy, whether primary of
metastatic, with histological confirmation of malignancy.
- Currently enrolled in hospice and referred for single fraction palliative
- Performance status (to be evaluated by the radiation oncologist), Karnofsky
Performance Scale ≥ 20 or ECOG Performance Scale < 5 .
- Ability to understand and willingness to sign a written informed consent document
- Unable to understand English.
- Unable to complete forms with assistance.
- Concurrent enrollment in a study of pain management involving medications or devices.
Type of Study:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Feasibility of treatment delivery in the same day as initial evaluation
Patient evaluation will consist of surveys conducted at the time of treatment measured by the Radiation Oncologist Evaluation and Feasibility Assessments survey
Outcome Time Frame:
Up to 6 months
Drew Moghanaki, MD, MPH
Virginia Commonwealth University
United States: Institutional Review Board
- Symptomatic Osseous Bone Lesions From Any Malignancy
- Neoplasm Metastasis
|Virginia Commonwealth University/Massey Cancer Center||Richmond, Virginia 23298|